Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation
✍ Scribed by Mano Horinaka; Tatsushi Yoshida; Susumu Nakata; Takumi Shiraishi; Mitsuhiro Tomosugi; Sae Yoshikawa; Miki Wakada; Toshiyuki Sakai
- Book ID
- 114703129
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 396 KB
- Volume
- 103
- Category
- Article
- ISSN
- 1347-9032
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Despite improvements in chemotherapy and surgery in the treatment of osteosarcoma (OS), satisfactory results are still difficult to achieve. Novel therapeutic modalities need to be developed for osteosarcoma treatment. The combined effects of tumor necrosis factor‐related apoptosis‐indu
## Abstract ## Objective To characterize the expression pattern of tumor necrosis factor–related apoptosis‐inducing ligand (TRAIL) and its cognate receptors (TRAIL R1, R2, R3, and R4) on rheumatoid arthritis (RA) synovial fluid (SF) lymphocytes and monocyte/macrophages and on cultured RA synovial